Commercial / Scale-Up Quality & Compliance

From Clinical Success to Commercial Excellence

Scaling to commercial manufacturing demands precision, consistency, and a quality system capable of withstanding the rigour of global regulatory inspections. BioCellGene partners with organisations transitioning to full-scale production to optimise QMS processes, validate facilities and systems, and embed a culture of continuous improvement.

We ensure your operations are not just compliant — but efficient, scalable, and inspection-resilient.

Why Commercial-Stage Quality Matters

Transitioning to commercial manufacturing introduces a new level of complexity and regulatory expectation. Common challenges include:

• Gaps between clinical systems and commercial GMP requirements

• Incomplete process validation or lifecycle management

• Data integrity and system robustness concerns

• Increased regulatory scrutiny (PAI / inspections)

• Inefficient or non-scalable QMS processes

• Supply chain and vendor compliance risks

At this stage, quality defines licence approval, market access, and long-term sustainability

Our Approach

We implement a fully integrated Pharmaceutical Quality System (PQS) aligned with:

• FDA (21 CFR Parts 210/211, PAI readiness)

• EMA / EU GMP (including Annex 1 & lifecycle validation)

• PIC/S GMP guidelines

• ICH Q8, Q9, Q10, and lifecycle process validation

• Data Integrity (ALCOA+) and digital compliance (CSV/CSA)

Our philosophy:

“Built for inspection. Designed for scale.”

What You Gain

By partnering with BioCellGene at commercial stage, you achieve:

✔Inspection-ready systems aligned with global regulatory expectations

✔ Successful navigation of PAI and regulatory approvals

✔ Robust, lifecycle-driven process validation framework

✔ Scalable and efficient QMS supporting commercial volumes

✔ Strong data integrity and digital compliance posture

✔ Sustainable quality culture across operations

Who This Is For

This service is ideal for:

• Organisations preparing for commercial manufacturing authorisation

• Companies approaching Pre-Approval Inspection (PAI)

• Biologics, pharmaceutical, and ATMP manufacturers scaling operations

• CRDMOs expanding into commercial production

• Teams upgrading from clinical to full GMP lifecycle compliance

When to Engage

The best time to engage is:

• During process scale-up and PPQ planning

• Prior to facility qualification or commercial readiness

• Before regulatory submissions (BLA / MAA / NDA)

• In preparation for PAI or routine GMP inspections

• When optimising or remediating mature QMS systems

Call to Action

Scale with Confidence. Operate with Excellence.

Partner with BioCellGene to build a commercial-ready quality system that supports regulatory approval, operational efficiency, and long-term success.

Book Your Complimentary 1-Hour Consultation